KODNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Kodiak Sciences Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$91.35+5.60 (+6.53%)
Close on Oct 19, 2026
- Market cap
- $5.72B
- P/E (TTM)
- –
- Dividend yield
- –
Kodiak Sciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Kodiak Sciences | Industry median |
|---|---|---|
| Market Cap | $5.74B | $197.05M |
| Enterprise Value | $5.62B | $106.56M |
| PB Ratio | 93.97 | 2.14 |
| P/TBV Ratio | 93.97 | 2.46 |
Income (trailing twelve months)
| Measure | Kodiak Sciences | Industry median |
|---|---|---|
| Operating Income | -$246.42M | -$21.44M |
| Net Income | -$241.99M | -$22.46M |
| EBITDA | -$246.42M | -$16.91M |
| EPS (Diluted) | -$4.19 | -$0.83 |
Returns
| Measure | Kodiak Sciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -368.4% | -53.1% |
| Return on Assets (ROA) | -94.2% | -41.0% |
| Return on Capital Employed (ROCE) | -120.8% | -37.8% |
Balance sheet
| Measure | Kodiak Sciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $125.90M | $62.42M |
| Net Cash (Debt) | $125.90M | $15.68M |
| Net Cash Per Share | $2.00 | $0.65 |
| Equity (Book Value) | $61.10M | $48.79M |
| Book Value Per Share | $0.97 | $1.36 |
| Tangible Book Value | $61.10M | $23.06M |
| Working Capital | $78.59M | $75.77M |
Financial position
| Measure | Kodiak Sciences | Industry median |
|---|---|---|
| Current Ratio | 2.49 | 3.30 |
| Quick Ratio | 2.39 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Kodiak Sciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$158.51M | -$12.35M |
| Capital Expenditures | -$1.40M | -$1.06M |
| Free Cash Flow | -$159.90M | -$20.28M |
| FCF Per Share | -$2.54 | -$0.41 |
Efficiency
| Measure | Kodiak Sciences | Industry median |
|---|---|---|
| Profits Per Employee | -$1.95M | -$732.08K |
| Employee Count | 124 | 73 |
Dividends and yields
| Measure | Kodiak Sciences | Industry median |
|---|---|---|
| Earnings Yield | -4.21% | -21.2% |
| FCF Yield | -2.79% | -7.64% |
Shares
| Measure | Kodiak Sciences | Industry median |
|---|---|---|
| Shares Outstanding | 62,849,500 | 59,128,900 |
| Shares Change (YoY) | 9.96% | 11.1% |
| Shares Change (QoQ) | 1.09% | 0.54% |
| Float | 18,009,300 | 48,744,500 |
| Shares Held by Insiders | 71.3% | 11.8% |
| Shares Held by Institutions | 96.2% | 59.4% |
Scores
| Measure | Kodiak Sciences | Industry median |
|---|---|---|
| Altman Z-Score | 5.63 | 0.10 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Kodiak Sciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.